Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt. [electronic resource]
- The Journal of biological chemistry Oct 2003
- 43603-14 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't